Prostate Specific Antigen (PSA) Test Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share

What market dynamics are playing a key role in accelerating the growth of the prostate specific antigen (psa) test market?
The growth of the prostate-specific antigen (PSA) test market is anticipated to be fuelled by the rising incidence of prostate cancer. This type of cancer originates from the prostate gland, an integral part of the reproductive system in both men and women. The PSA test is a popular method used for screening prostate cancer in men as it helps in early detection and assessing risk by evaluating the PSA levels in the bloodstream. For example, the American Society of Clinical Oncology (ASCO), a professional oncology organization based in the US, reported in March 2023 that around 288,300 men were found to have prostate cancer and nearly 34,700 people succumbed to the disease in the same year, in the US alone. Thus, the increasing frequency of prostate cancer is a major factor propelling the growth of the PSA test market.

Get Your Prostate Specific Antigen (PSA) Test Market Report Here:
https://www.thebusinessresearchcompany.com/report/prostate-specific-antigen-psa-test-global-market-report

How will the growth rate of the prostate specific antigen (psa) test market shape industry trends by 2034?
In recent times, the market size for the Prostate Specific Antigen (PSA) test has experienced swift expansion. The market is projected to rise from a worth of $4.15 billion in 2024 to $4.66 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 12.1%. Factors contributing to this growth in the past have been heightened awareness, an aging population, progress in the medical sector, specific clinical recommendations, and advancements in the pharmaceutical field.

In the coming years, the market size for the prostate specific antigen (PSA) test is predicted to witness swift expansion. It is expected to reach a value of $7.29 billion by 2029, with a compound annual growth rate (CAGR) of 11.9%. The increase in the prediction period is ascribed to progress in test accuracy, individualized medicine methods, and an aging global population. Key market trends in the future are expected to be a shift towards the use of biomarker combinations, advancements in technology, point-of-care testing, integration of digital health, and a focus on early detection and prevention.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12576&type=smp

What new trends are reshaping the prostate specific antigen (psa) test market and its opportunities?
The central trend shaping the prostate-specific antigen (PSA) test market is technological innovation. Leading companies within the PSA test market are leveraging cutting-edge screening test equipment to maintain their competitiveness. For instance, in February 2023, LynxDx Inc., a US-established diagnostic firm, unveiled MyProstateScore 2.0, a non-invasive urine prostate cancer screening examination. This groundbreaking test leverages a group of 18 biomarkers, inclusive of the new gene fusion T2:ERG, to generate a tailored risk evaluation for each patient. Additionally, this screening test delivers precise, tiered risk assessment data to inform clinical judgments for patients exhibiting elevated prostate-specific antigen (PSA) or irregular digital rectal exam (DRE) results. Furthermore, it holds promise for enhancing prostate cancer screening and treatment methods.

Which primary segments of the prostate specific antigen (psa) test market are driving growth and industry transformations?
The prostate specific antigen (PSA) test market covered in this report is segmented -

1) By Type: Clinical Laboratory Improvement Amendments (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Fluorescence Immunoassay (FIA), Other Types
2) By Application: Screening, Post-Treatment Monitoring, Other Applications
3) By End User: Hospitals, Diagnostic Centers, Research Institutes, Other End Users

Subsegments:
1) By Clinical Laboratory Improvement Amendments (CLIA): CLIA Waived Tests, Non-CLIA Tests
2) By Enzyme-Linked Immunosorbent Assay (ELISA): Sandwich ELISA Kits, Competitive ELISA Kits
3) By Fluorescence Immunoassay (FIA): Point-Of-Care FIA, Laboratory-Based FIA
4) By Other Types: Chemiluminescent Immunoassay (CLIA), Radioimmunoassay (RIA)

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12576

Which geographical regions are pioneering growth in the prostate specific antigen (psa) test market?
North America was the largest region in the prostate specific antigen (PSA) test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate specific antigen (PSA) test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the influential players reshaping the prostate specific antigen (psa) test market landscape?
Major companies operating in the prostate specific antigen (PSA) test market include Siemens AG, F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Becton Dickinson and Company, PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin SpA, OPKO Health Inc., R&D Systems Inc., Meso Scale Diagnostics LLC, Tosoh America Inc., Fujirebio Europe N.V., Boditech Med Inc., DRG International Inc., BioVision Inc., Enzo Life Sciences Inc., RayBiotech Inc., Novus Biologicals LLC, Creative Diagnostics Inc., Elabscience, LifeSpan BioSciences Inc., American Laboratory Products Company Ltd., Accuquik Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12576&type=smp

What Is Covered In The Prostate Specific Antigen (PSA) Test Global Market Report?

• Market Size Forecast: Examine the prostate specific antigen (psa) test market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the prostate specific antigen (psa) test market for a structured understanding.
• Key Players Overview: Analyze major players in the prostate specific antigen (psa) test market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the prostate specific antigen (psa) test market.
• Segment Contributions: Evaluate how different segments drive overall growth in the prostate specific antigen (psa) test market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the prostate specific antigen (psa) test market.
• Industry Challenges: Identify potential risks and obstacles affecting the prostate specific antigen (psa) test market.
• Competitive Landscape: Review strategic developments in the prostate specific antigen (psa) test market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.